Analysis of glioblastoma patients' plasma revealed the presence of microRNAs with a prognostic impact on survival and those of viral origin

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Herman, Ana ^a   Gruden, Kristina ^b   Blejec, Andrej ^b   Podpečan, Vid ^c   Motaln, Helena ^b   Rožman, Primož ^a   Hren, Matjaž ^d   Zupančič, Klemen ^d   Veber, Matija ^e   Verbovšek, Urška ^b   Turnšek, Tamara Lah ^b,g   Porčnik, Andrej ^f   Koršič, Marjan ^f   Knežević, Miomir ^e   Jeras, Matjaž ^g  

^a BLOOD TRANSFUSION CENTRE OF SLOVENIA   (Slovenia)

^b NATIONAL INSTITUTE OF BIOLOGY   (Slovenia)

^c JO EF STEFAN INSTITUTE   (Slovenia)

^d BioSistemika Ltd   (Slovenia)

^e Educell Ltd   (Slovenia)

^f UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^g UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

HSA MICRORNA 514A 3P; HSA MICRORNA 592; MICRORNA; TUMOR MARKER; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC TEST; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; RNA ANALYSIS; SIGNAL TRANSDUCTION; VIRUS INFECTION; BLOOD; BRAIN TUMOR; CASE CONTROL STUDY; GENETICS; PATHOLOGY; PROGNOSIS; SURVIVAL ANALYSIS; VIROLOGY;

BRAIN NEOPLASMS; CASE-CONTROL STUDIES; GLIOBLASTOMA; HUMANS; MICRORNAS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84929207584     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125791     Document Type: Article

References (74)

1. Parsons DW, Jones S, Zhang X, Lin JC-H, Leary RJ, Angenendt P, et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme. Science. 2008; 321: 1807-1812. doi: 10.1126/science.1164382 PMID: 18772396
2. Van Meir EG, Hadjipanayis CG, Norden AD, Shu H-K, Wen PY, Olson JJ. Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma. CA: A Cancer Journal for Clinicians. 2010; 60: 166-193. doi: 10.3322/caac.20069 PMID: 20445000
3. Nikaki A, Piperi C, Papavassiliou AG. Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy. Expert Opinion on Investigational Drugs. 2012; 21: 1475-1488. doi: 10.1517/13543784.2012.710199 PMID: 22809292
4. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116: 281-297. doi: 10.1016/S0092-8674(04)00045-5 PMID: 14744438
5. Turner JD, Williamson R, Almefty KK, Nakaji P, Porter R, Tse V, et al. The many roles of microRNAs in brain tumor biology. Neurosurg Focus. 2010; 28: E3. doi: 10.3171/2009.10.FOCUS09207 PMID: 20568943
6. Wang K, Zhang S, Weber J, Baxter D, Galas DJ. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucl Acids Res. 2010; 38: 7248-7259. doi: 10.1093/nar/gkq601 PMID: 20615901
7. Wittmann J, Jäck H-M. Serum microRNAs as powerful cancer biomarkers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2010; 1806: 200-207. doi: 10.1016/j.bbcan.2010.07.002
8. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, et al. Serum MicroRNAs Are Promising Novel Biomarkers. PLoS ONE. 2008; 3: e3148. doi: 10.1371/journal.pone.0003148 PMID: 18773077
9. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008; 18: 997-1006. doi: 10.1038/cr.2008.282 PMID: 18766170
10. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences. 2008; 105: 10513-10518. doi: 10.1073/pnas.0804549105 PMID: 18663219
11. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecologic oncology. 2008; 110: 13-21. doi: 10.1016/j.ygyno.2008.04.033 PMID: 18589210
12. De Smaele E, Ferretti E, Gulino A. MicroRNAs as biomarkers for CNS cancer and other disorders. Brain Research. 2010; 1338: 100-111. doi: 10.1016/j.brainres.2010.03.103 PMID: 20380821
13. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, et al. Detection of microRNA Expression in Human Peripheral Blood Microvesicles. PLoS ONE. 2008; 3. doi: 10.1371/journal.pone.0003694
14. Duttagupta R, Jiang R, Gollub J, Getts RC, Jones KW. Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures. PLoS ONE. 2011; 6: e20769. doi: 10.1371/journal.pone.0020769 PMID: 21698099
15. Karsy M, Arslan E, Moy F. Current Progress on Understanding MicroRNAs in Glioblastoma Multiforme. Genes & Cancer. 2012; 3: 3-15. doi: 10.1177/1947601912448068
16. Roth P, Wischhusen J, Happold C, Chandran PA, Hofer S, Eisele G, et al. A specific miRNA signature in the peripheral blood of glioblastoma patients. Journal of Neurochemistry. 2011; doi: 10.1111/j.1471-4159.2011.07307.x
17. Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Curry WT, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10: 1470-1476. doi: 10.1038/ncb1800 PMID: 19011622
18. Wang Q, Li P, Li A, Jiang W, Wang H, Wang J, et al. Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma. J Exp Clin Cancer Res. 2012; 31: 97. doi: 10.1186/1756-9966-31-97 PMID: 23174013
19. Ilhan-Mutlu A, Wagner L, Wöhrer A, Furtner J, Widhalm G, Marosi C, et al. Plasma MicroRNA-21 Concentration May Be a Useful Biomarker in Glioblastoma Patients. Cancer Invest. 2012; 30: 615-621. doi: 10.3109/07357907.2012.708071 PMID: 22891879
20. Pfeffer S, Voinnet O. Viruses, microRNAs and cancer. Oncogene. 2006; 25: 6211-6219. doi: 10.1038/sj.onc.1209915 PMID: 17028601
21. Etheridge A, Lee I, Hood L, Galas D, Wang K. Extracellular microRNA: a new source of biomarkers. Mutat Res. 2011; 717: 85-90. doi: 10.1016/j.mrfmmm.2011.03.004 PMID: 21402084
22. Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotech. 2008; 26: 317-325. doi: 10.1038/nbt1385
23. Gruden K, Hren M, Herman A, Blejec A, Albrecht T, Selbig J, et al. A "crossomics" study analysing variability of different components in peripheral blood of healthy caucasoid individuals. PLoS ONE. 2012; 7: e28761. doi: 10.1371/journal.pone.0028761 PMID: 22253695
24. Fortina P, Surrey S. Digital mRNA profiling. Nat Biotech. 2008; 26: 293-294. doi: 10.1038/nbt0308-293
25. Reid G, Kirschner MB, van Zandwijk N. Circulating microRNAs: Association with disease and potential use as biomarkers. Crit Rev Oncol Hematol. 2011; 80: 193-208. doi: 10.1016/j.critrevonc.2010.11.004 PMID: 21145252
26. Brase JC, Wuttig D, Kuner R, Sültmann H. Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer. 2010; 9: 306. doi: 10.1186/1476-4598-9-306 PMID: 21110877
27. Griffiths-Jones S, Saini HK, Dongen S van, Enright AJ. miRBase: tools for microRNA genomics. Nucl Acids Res. 2008; 36: D154-D158. doi: 10.1093/nar/gkm952 PMID: 17991681
28. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques. 2003; 34: 374. PMID: 12613259
29. Kaplan EL, Meier P. Nonparametric Estimation from Incomplete Observations. Journal of the American Statistical Association. 1958; 53: 457. doi: 10.2307/2281868
30. Robnik-Šikonja M, Kononenko I. Theoretical and Empirical Analysis of ReliefF and RReliefF. Machine Learning. 2003; 53: 23-69. doi: 10.1023/A:1025667309714
31. Hsu S-D, Lin F-M, Wu W-Y, Liang C, Huang W-C, Chan W-L, et al. miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucl Acids Res. 2010; gkq1107. doi: 10.1093/nar/gkq1107
32. Paraskevopoulou MD, Georgakilas G, Kostoulas N, Vlachos IS, Vergoulis T, Reczko M, et al. DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows. Nucleic Acids Res. 2013; 41: W169-173. doi: 10.1093/nar/gkt393 PMID: 23680784
33. Friedman RC, Farh KK-H, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009; 19: 92-105. doi: 10.1101/gr.082701.108 PMID: 18955434
34. Eronen L, Toivonen H. Biomine: predicting links between biological entities using network models of heterogeneous databases. BMC Bioinformatics. 2012; 13: 119. doi: 10.1186/1471-2105-13-119 PMID: 22672646
35. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007; 129: 1401-1414. doi: 10.1016/j.cell.2007.04.040 PMID: 17604727
36. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila). 2012; 5: 492-497. doi: 10.1158/1940-6207.CAPR-11-0370 PMID: 22158052
37. Podpečan V, Lavrač N, Mozetič I, Novak PK, Trajkovski I, Langohr L, et al. SegMine workflows for semantic microarray data analysis in Orange4WS. BMC Bioinformatics. 2011; 12: 416. doi: 10.1186/1471-2105-12-416 PMID: 22029475
38. Trajkovski I, Lavrač N, Tolar J. SEGS: Search for enriched gene sets in microarray data. Journal of Biomedical Informatics. 2008; 41: 588-601. doi: 10.1016/j.jbi.2007.12.001 PMID: 18234563
39. Dweep H, Sticht C, Pandey P, Gretz N. miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes. Journal of Biomedical Informatics. 2011; 44: 839-847. doi: 10.1016/j.jbi.2011.05.002 PMID: 21605702
40. Xie B, Ding Q, Han H, Wu D. miRCancer: a microRNA - cancer association database constructed by text mining on literature. Bioinformatics. 2013; 29: 638-644. doi: 10.1093/bioinformatics/btt014 PMID: 23325619
41. Lagana A, Forte S, Giudice A, Arena MR, Puglisi PL, Giugno R, et al. miRo: a miRNA knowledge base. Database. 2009; 2009: bap008-bap008. doi: 10.1093/database/bap008 PMID: 20157481
42. He Z, Cen D, Luo X, Li D, Li P, Liang L, et al. Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor. Med Oncol. 2013; 30: 557. doi: 10.1007/s12032-013-0557-0 PMID: 23564324
43. Søkilde R, Vincent M, Møller AK, Hansen A, Høiby PE, Blondal T, et al. Efficient Identification of miRNAs for Classification of Tumor Origin. The Journal of Molecular Diagnostics. 2014; 16: 106-115. doi: 10.1016/j.jmoldx.2013.10.001 PMID: 24211363
44. Rogler A, Hoja S, Socher E, Nolte E, Wach S, Wieland W, et al. Role of two single nucleotide polymorphisms in secreted frizzled related protein 1 and bladder cancer risk. Int J Clin Exp Pathol. 2013; 6: 1984-1998. PMID: 24133576
45. Ciafrè SA, Galardi S, Mangiola A, Ferracin M, Liu C-G, Sabatino G, et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochemical and Biophysical Research Communications. 2005; 334: 1351-1358. doi: doi:16/j.bbrc.2005.07.030 PMID: 16039986
46. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G, et al. Targeting of the Bmi-1 Oncogene/Stem Cell Renewal Factor by MicroRNA-128 Inhibits Glioma Proliferation and Self-Renewal. Cancer Res. 2008; 68: 9125-9130. doi: 10.1158/0008-5472.CAN-08-2629 PMID: 19010882
47. Silber J, Lim D, Petritsch C, Persson A, Maunakea A, Yu M, et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Medicine. 2008; 6: 14. doi: 10.1186/1741-7015-6-14 PMID: 18577219
48. Sasayama T, Nishihara M, Kondoh T, Hosoda K, Kohmura E. MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int J Cancer. 2009; 125: 1407-1413. doi: 10.1002/ijc.24522 PMID: 19536818
49. Lang M-F, Yang S, Zhao C, Sun G, Murai K, Wu X, et al. Genome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells. PLoS ONE. 2012; 7: e36248. doi: 10.1371/journal.pone.0036248 PMID: 22558405
50. Srinivasan S, Patric IRP, Somasundaram K. A Ten-microRNA Expression Signature Predicts Survival in Glioblastoma. PLoS ONE. 2011; 6: e17438. doi: 10.1371/journal.pone.0017438 PMID: 21483847
51. Raabe CA, Tang T-H, Brosius J, Rozhdestvensky TS. Biases in small RNA deep sequencing data. Nucl Acids Res. 2013; gkt1021. doi: 10.1093/nar/gkt1021 PMID: 23761435
52. Reis PP, Waldron L, Goswami RS, Xu W, Xuan Y, Perez-Ordonez B, et al. mRNA transcript quantification in archival samples using multiplexed, color-coded probes. BMC Biotechnol. 2011; 11: 46. doi: 10.1186/1472-6750-11-46 PMID: 21549012
53. Bozdag S, Li A, Riddick G, Kotliarov Y, Baysan M, Iwamoto FM, et al. Age-Specific Signatures of Glioblastoma at the Genomic, Genetic, and Epigenetic Levels. PLoS ONE. 2013; 8: e62982. doi: 10.1371/journal.pone.0062982 PMID: 23658659
54. Shi L, Fei X, Sun G, Wang Z, Wan Y, Zeng Y, et al. Hypothermia Stimulates Glioma Stem Spheres to Spontaneously Dedifferentiate Adjacent Non-stem Glioma Cells. Cell Mol Neurobiol. 2014; 1-14. doi: 10.1007/s10571-014-0114-1 PMID: 25096398
55. Henriksen M, Johnsen KB, Andersen HH, Pilgaard L, Duroux M. MicroRNA Expression Signatures Determine Prognosis and Survival in Glioblastoma Multiforme - a Systematic Overview. Mol Neurobiol. 2014; 1-18. doi: 10.1007/s12035-014-8668-y PMID: 25236258
56. Tunca B, Tezcan G, Cecener G, Egeli U, Ak S, Malyer H, et al. Olea europaea leaf extract alters micro-RNA expression in human glioblastoma cells. J Cancer Res Clin Oncol. 2012; 138: 1831-1844. doi: 10.1007/s00432-012-1261-8 PMID: 22722712
57. Wang L, Shi M, Hou S, Ding B, Liu L, Ji X, et al. MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1. FEBS Lett. 2012; 586: 1312-1317. doi: 10.1016/j.febslet.2012.03.035 PMID: 22465663
58. Kunder R, Jalali R, Sridhar E, Moiyadi A, Goel N, Goel A, et al. Real-time PCR assay based on the differential expression of microRNAs and protein-coding genes for molecular classification of formalin-fixed paraffin embedded medulloblastomas. Neuro-oncology. 2013; 15: 1644-1651. doi: 10.1093/neuonc/not123 PMID: 24203893
59. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr, Sjoblom T, et al. The colorectal microRNAome. Proc Natl Acad Sci USA. 2006; 103: 3687-3692. doi: 10.1073/pnas.0511155103 PMID: 16505370
60. Wang W, Zhao L-J, Tan Y-X, Ren H, Qi Z-T. MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma. Carcinogenesis. 2012; 33: 1113-1120. doi: 10.1093/carcin/bgs113 PMID: 22362728
61. Oberg AL, French AJ, Sarver AL, Subramanian S, Morlan BW, Riska SM, et al. miRNA Expression in Colon Polyps Provides Evidence for a Multihit Model of Colon Cancer. PLoS One. 2011; 6. doi: 10.1371/journal.pone.0020465
62. Sarver AL, French AJ, Borralho PM, Thayanithy V, Oberg AL, Silverstein KA, et al. Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer. 2009; 9: 401. doi: 10.1186/1471-2407-9-401 PMID: 19922656
63. Boss IW, Renne R. Viral miRNAs: tools for immune evasion. Curr Opin Microbiol. 2010; 13: 540-545. doi: 10.1016/j.mib.2010.05.017 PMID: 20580307
64. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, Eijndhoven MAJ van, Hopmans ES, Lindenberg JL, et al. Functional delivery of viral miRNAs via exosomes. PNAS. 2010; 107: 6328-6333. doi: 10.1073/pnas.0914843107 PMID: 20304794
65. Ramalingam D, Kieffer-Kwon P, Ziegelbauer JM. Emerging Themes from EBV and KSHV microRNA Targets. Viruses. 2012; 4: 1687-1710. doi: 10.3390/v4091687 PMID: 23170179
66. Flores O, Nakayama S, Whisnant AW, Javanbakht H, Cullen BR, Bloom DC. Mutational Inactivation of Herpes Simplex Virus 1 MicroRNAs Identifies Viral mRNA Targets and Reveals Phenotypic Effects in Culture. J Virol. 2013; 87: 6589-6603. doi: 10.1128/JVI.00504-13 PMID: 23536669
67. Dhuruvasan K, Sivasubramanian G, Pellett PE. Roles of host and viral microRNAs in human cytomegalovirus biology. Virus Research. 2011; 157: 180-192. doi: 10.1016/j.virusres.2010.10.011 PMID: 20969901
68. Shen Z-Z, Pan X, Miao L-F, Ye H-Q, Chavanas S, Davrinche C, et al. Comprehensive Analysis of Human Cytomegalovirus MicroRNA Expression during Lytic and Quiescent Infection. PLoS ONE. 2014; 9: e88531. doi: 10.1371/journal.pone.0088531 PMID: 24533100
69. Abreu MM, Sealy L. The C/EBPbeta isoform, liver-inhibitory protein (LIP), induces autophagy in breast cancer cell lines. Experimental Cell Research. 2010; 316: 3227-3238. doi: 10.1016/j.yexcr.2010.07.021 PMID: 20699097
70. Lin Z, Flemington EK. miRNAs in the pathogenesis of oncogenic human viruses. Cancer Letters. 2011; 305: 186-199. doi: 10.1016/j.canlet.2010.08.018 PMID: 20943311
71. Marquitz AR, Mathur A, Nam CS, Raab-Traub N. The Epstein - Barr Virus BART microRNAs target the pro-apoptotic protein Bim. Virology. 2011; 412: 392-400. doi: 10.1016/j.virol.2011.01.028 PMID: 21333317
72. Skalsky RL, Corcoran DL, Gottwein E, Frank CL, Kang D, Hafner M, et al. The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines. PLoS Pathog. 2012; 8: e1002484. doi: 10.1371/journal. ppat.1002484 PMID: 22291592
73. Lagana A, Forte S, Russo F, Giugno R, Pulvirenti A, Ferro A. Prediction of human targets for viral-encoded microRNAs by thermodynamics and empirical constraints. J RNAi Gene Silencing. 2010; 6: 379-385. PMID: 20628498
74. Tiso N, Pallavicini A, Muraro T, Zimbello R, Apolloni E, Valle G, et al. Chromosomal localization of the human genes, CPP32, Mch2, Mch3, and Ich-1, involved in cellular apoptosis. Biochem Biophys Res Commun. 1996; 225: 983-989. doi: 10.1006/bbrc.1996.1282 PMID: 8780721